Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Here's what you need to know about the possible next generation of shots. Moderna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to getting ...

The first time I got a Novavax Covid vaccine, it felt almost subversive. Over the previous few years, every mRNA-based booster I’d gotten — the ones made by Moderna and Pfizer — had felt ...

A scientist surrounded by vials and beakers in ... notably its COVID-19 vaccine, which is its first commercially approved product. Moderna, Inc. (NASDAQ:MRNA) has faced significant challenges ...

The shift in strategy comes as Moderna has seen a sharp decline in sales of its COVID-19 vaccine, including a 37% year-over-year decrease in its most recent quarter. In the release, Moderna also ...

Anyone who lived through the first year of the COVID-19 pandemic remembers that ... or steal to get Pfizer or Moderna vaccines to save them. Even prime ministers and presidents were involved ...

A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine ... Looking beyond COVID, we think Moderna has the potential to disrupt the biopharmaceutical ...